0
Skip to Content
Wesana Health
Current Page: Team
Newsroom
Contact
Investors
Wesana Health
Current Page: Team
Newsroom
Contact
Current Page: Team
Newsroom
Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Stock Information
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • Governance
    • Board of Directors
    • Governance Documents
  • SEDAR
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 22, 2022 7:30am EDT

Wesana Health Announces New Findings Indicating Psilocybin Potentiates Impact of an Anti-Depressant

Mar 14, 2022 9:07am EDT

Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

Mar 11, 2022 5:00pm EST

Wesana Provides Updates on Build-out of Third Clinic

Jan 25, 2022 7:30am EST

Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer

Jan 18, 2022 7:30am EST

Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol

Jan 12, 2022 7:00am EST

Wesana Health Provides Strategic and Operational Updates

Jan 11, 2022 7:00am EST

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Dec 14, 2021 7:32am EST

MAPS and Wesana Health Resume Negotiations

Dec 09, 2021 7:30am EST

Wesana Completes Filing of PCT Patents for Novel Drug Protocols

Nov 29, 2021 7:05pm EST

Wesana Health Reports Q3 2021 Financial Results

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
RSS
  • email Email Alerts
  • location_city Company Profile
  • perm_contact_calendar Contacts
  • rss_feed RSS News Feed

© Wesana Health